VEGFA and fetal growth restriction: The mere association of CP with anti-VEGF therapy in the included studies where adjusted analysis was not possible could be due to the infants who received anti-VEGF being sicker, smaller, or with other comorbidities such as IVH or impaired microvascular development (BDP or IUGR).